Stock ATLN ACTELION
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Actelion

Equities

ATLN

CH0010532478

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Actelion : Pharmaceuticals US, Inc, - Results from Expert Delphi Consensus Survey on Treatment of Pulmonary Arterial Hypertension with Oral Prostacyclin Pathway Agents
AQ
Actelion : Cancellation of publicly held Actelion shares and delisting from SIX Swiss Exchange as of November 7, 2017
GL
Actelion : France's Sanofi raises earnings forecast, pleased with eczema drug uptake
RE
Johnson & Johnson : J&J sees sales growth in near-term; raises 2017 profit forecast
RE
Johnson & Johnson : J&J sees sales growth in near-term; raises 2017 profit forecast
RE
Actelion : Befreiung von Publizitätspflichten zur Aufrechterhaltung der Kotierung
GL
Actelion : Johnson & Johnson Completes Acquisition of Actelion
GL
Actelion : Publication of Idorsia's prospectus relating to the listing of Idorsia Ltd on SIX Swiss Exchange
PU
Actelion : announces changes to its executive team upon completion of the transaction with Johnson & Johnson
GL
Spin off
FA
Actelion : Johnson & Johnson expects to complete Actelion purchase on June 16
RE
Actelion : Johnson & Johnson expects to complete Actelion purchase on June 16
RE
Actelion : Johnson & Johnson expects to complete of Actelion offer on June 16
RE
Actelion : Publication of Idorsia's prospectus relating to the listing of Idorsia Ltd on SIX Swiss Exchange
GL
Actelion : Johnson & Johnson announces expected settlement of Actelion tender offer on June 16, 2017
GL
Actelion : provides an update on the Phase III IMPACT program with cadazolid in CDAD
GL
Akzo Nobel : Cross-border M&A between U.S. and European firms at 10 year high
RE
Actelion : provides an update on the progress towards launching Idorsia - Key results for pipeline assets to be developed by Idorsia
GL
Actelion : Johnson & Johnson offers EU concessions over Actelion deal
RE
Actelion : announces changes to its executive team upon completion of the transaction with Johnson & Johnson
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ATLN Stock
  4. News Actelion